A new treatment option for Clostridium difficile: Fecal transplantation

March 14, 2012

Fecal transplantation through colonoscopy is an effective treatment for recurrent Clostridium difficile infection (CDI), according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association. Additionally, the mortality rate in this study does not appear to be greater than in some previously reported series, suggesting that fecal transplantation itself seems to be a rather safe procedure. CDI is a common cause of both community- and hospital-acquired diarrhea, usually occurring after exposure to antibiotics.

"Our results suggest that fecal transplantation is clearly better than any other treatment for recurrent Clostridium difficile infection," said Eero Mattila, MD, of Helsinki University Central Hospital, , and lead author of this study. "Although fecal transplantation is not simple to perform and it has potential risks, it is an effective option."

A team of researchers reviewed records from 70 patients — across five hospitals — with recurrent CDI who had undergone fecal transplantation through colonoscopy. Donor stool was manually homogenized before transplantation, and fecal transplantation was performed at by infusing fresh donor feces into the cecum. During the first 12 weeks after fecal transplantation, symptoms were alleviated in all patients who did not have the dangerous Clostridium difficile 027 strain. Of the 36 patients with this strain, 89 percent had a favorable response. After the initial 12 weeks of follow-up, no serious adverse events related to fecal transplantation could be observed during a one-year period. This is an outstanding result in a patient group unresponsive to other treatment methods.

During the past few years, CDI has become more frequent, more severe, more resistent to standard treatment, and more likely to relapse. Current treatment with is suboptimal and has limited efficacy, leading to recurrences in up to 50 percent of patients. However, a number of new approaches have been used to treat multiple CDI recurrences, and currently, there are a few attractive treatment options for relapsing disease.

Explore further: Research identifies new way to treat common hospital-acquired infection

More information: www.gastrojournal.org/

Related Stories

Recommended for you

Faster detection of pathogens in the lungs

June 24, 2016

What used to take several weeks is now possible in two days: Thanks to new molecular-based methods, mycobacterial pathogens that cause pulmonary infections or tuberculosis can now be detected much more quickly. Time-consuming ...

Researchers discover how West Nile virus triggers memory loss

June 22, 2016

Researchers at the University of Colorado Anschutz Medical Campus have discovered how the most severe forms of West Nile virus cause memory loss and mood disorders, opening the door to potential new treatments for the mosquito-borne ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.